Tracking and tackling the tumor dynamics clonal evolution: osimertinib rechallenge after interval therapy might be an effective treatment approach in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC)

作者：Giulio Metro, Angelo Bonaiti, Ilaria Birocchi, Francesca Marasciulo, Martina Ubaldi, Niccolò Metelli, Vincenzo Minotti, Alfredo Addeo · 发表于：Journal of Thoracic Disease · 年份：2022 · DOI：10.21037/jtd-22-98 · 被引用次数：5 · 研究领域：Lung Cancer Treatments and Mutations、Cancer Genomics and Diagnostics、PI3K/AKT/mTOR signaling in cancer

Tracking and tackling the tumor dynamics clonal evolution: osimertinib rechallenge after interval therapy might be an effective treatment approach in epidermal growth factor receptor ( EGFR )-mutant non-small cell lung cancer (NSCLC)